Agios Pharmaceuticals, Inc.
(NASDAQ : AGIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.56%58.070.0%$1728.62m
GILDGilead Sciences, Inc. -0.25%75.131.0%$1315.09m
REGNRegeneron Pharmaceuticals, Inc. 0.78%582.732.5%$968.87m
AMGNAmgen, Inc. 0.07%224.281.3%$646.77m
NVAXNovavax, Inc. 1.09%45.33102.0%$586.06m
VRTXVertex Pharmaceuticals, Inc. 0.11%277.701.9%$545.33m
BIIBBiogen, Inc. 0.21%301.131.6%$411.26m
ILMNIllumina, Inc. -1.89%365.973.5%$381.84m
SRNESorrento Therapeutics, Inc. -0.30%4.941.8%$297.10m
ALXNAlexion Pharmaceuticals, Inc. 1.11%115.702.0%$268.02m
SGENSeattle Genetics, Inc. 0.44%152.226.1%$255.63m
AAgilent Technologies, Inc. 0.72%87.311.6%$200.94m
BMRNBioMarin Pharmaceutical, Inc. -0.75%104.814.3%$178.43m
CODXCo-Diagnostics, Inc. -0.83%17.320.0%$169.39m
INCYIncyte Corp. -0.53%100.022.5%$156.66m

Company Profile

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.